Skip to main content
Signal8

Ros Matthew E

SEC insider (Form 3/4/5 filer). CIK 0001461613. Chief Operating Officer at Jasper Therapeutics, Inc. (JSPR). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 20, 2026. Located in REDWOOD CITY, CA.

Companies Ros Matthew E has filed insider reports for

  • Jasper Therapeutics, Inc. (JSPR): Officer, Chief Operating Officer
Ros Matthew E profile photo

Ros Matthew E

CIK: 0001461613

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 20, 2026
    Purchase

    Non-Voting Convertible Preferred Stock

    Direct
    881 shares-

1-1 of 1